| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/04/2002 | US6399341 Artificial pancreas |
| 06/04/2002 | US6399334 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
| 06/04/2002 | US6399331 Method for culturing recombinant cells |
| 06/04/2002 | US6399330 Nucleotide and amino acid sequences of crystal/insecticidal proteins; active against japanese beetle and red flour beetle; biological pest control |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399321 Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399308 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 06/04/2002 | US6399300 Recombinant embryonic cardiomyocyte cell having two constructs which are selectable marker genes under control of separate promoters; gene therapy; drug screening |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6399057 Method for the propagation of hair |
| 06/04/2002 | US6399054 Mhc restricted, tumor-specific t cells; incubating with ternary complex of biotinylated antibody against cell surface antigen, an avidin, streptavidin or neutravidin ligand, and biotinylated b7-ig, co-cultivating tumor cells with t cells |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | US6398819 Method and construct for producing graft tissue from an extracellular matrix |
| 06/04/2002 | CA2331934A1 Protein and its encoding nucleotide sequences for diagnosis, prevention and treatment of lung injuries and disorders |
| 06/04/2002 | CA2237805C Nucleic acid molecule encoding a 11-cis retinol dehydrogenase |
| 06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
| 06/01/2002 | CA2325666A1 Immunogenic mutated peptides derived from r9m, polynucleotides, coding polynucleotides and their therapeutic uses |
| 06/01/2002 | CA2325088A1 Novel membrane fusion proteins derived from poikilothermic reovirus |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042767A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042470A1 Isolated luciferases and the use thereof |
| 05/30/2002 | WO2002042469A1 Isolated luciferases lu164, lual and lu22, and the use of the same |
| 05/30/2002 | WO2002042468A2 Glycosyltransferase vectors for treating cancer |
| 05/30/2002 | WO2002042467A2 Aspergillus fumigatus profilin |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042461A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042451A2 Aspergillus fumigatus cofilin |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042434A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells |
| 05/30/2002 | WO2002042433A1 Method of amplifying natural killer cells shifting into th2 or th1 type |
| 05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
| 05/30/2002 | WO2002042431A2 Isolation procedure and optimized media solution to enhance long-term survival of cells |
| 05/30/2002 | WO2002042419A2 Cell culture apparatus and methods of use |
| 05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
| 05/30/2002 | WO2002042413A2 Methods and compositions involved in groucho-mediated differentiation |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042324A1 Gene encoding protein cluster i and the encoded protein |
| 05/30/2002 | WO2002041930A2 Connective tissue substitutes, method of preparation and uses thereof |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
| 05/30/2002 | WO2002017980A3 Methods and compositions for tissue regeneration |
| 05/30/2002 | WO2002011785A3 Manipulation of arterial-venous identity |
| 05/30/2002 | WO2002010346A3 Insulin producing cell-line obtained by electrofusion |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2001094598A3 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
| 05/30/2002 | WO2001094562A3 Cold sensitive mutant dna polymerases |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001089539A3 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression |
| 05/30/2002 | WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
| 05/30/2002 | WO2001073094A3 Novel sperm-dna complexes for genetically modifying non-human animals |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001068814A3 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001048187A3 A molecular switch for regulating mammalian gene expression |
| 05/30/2002 | WO2001045494A9 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
| 05/30/2002 | WO2001042509A9 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 05/30/2002 | WO2001039600A9 Use of hsp27 as an anti-inflammatory agent |
| 05/30/2002 | WO2001038511A8 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/30/2002 | WO2001034821A3 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 05/30/2002 | WO2001031058A3 Identification of cells for transplantation |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020066119 Regulatory sequences for use in generation of disease and damage resistant plants |
| 05/30/2002 | US20020065408 Generating heterologous proteins in eukaryotic cells; obtain cell, transform, express vector, recover heterologous protein |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
| 05/30/2002 | US20020065241 A recombinant polynucleotide of first polynucleotides coding an antigenic peptide and are operatively linked to each other to enhance translation of the polynucleotides to the peptides and binding to MHC; cancer vaccine |
| 05/30/2002 | US20020065239 Antidiabetic agents; obesity and diabetic-related conditions; administration of vectors encoding the following: glucokinase regulatory protein alone or co-administered with glucokinase or with metabolism modififying proteins |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065212 Methods of treating disease using sertoli cells and allografts or xenografts |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064877 Methods of producing and using a human microglial cell line |
| 05/30/2002 | US20020064875 Solid support for use in joining or fixation of aggregates in culture |
| 05/30/2002 | US20020064874 Generating preferential immune response cells; depleting preferential antigen from sample, incubate with binding protein, recover cells expressing marker protein, amplify cells |